MetaCap

Pulmatrix (PULM) vs Scienture (SCNX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Pulmatrix is the larger company by market cap ($4.6 million vs $4.1 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PULM-14.77%SCNX-44.85%
+8%-20%-47%
Oct 7, 20261 yearNov 20, 2026
PULM-13.01%SCNX-39.42%
+3%-19%-41%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PULM versus SCNX key metrics
MetricPULMSCNX
Share price$1.27$2.28
Market cap$4.64M$4.07M
1-day change-10.56%-6.45%
EPS (TTM)$-1.20$-51.70
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$431.61K
Revenue growth (YoY)—+215.87%
Net income (latest FY)$-5.16M$-41.51M
Gross margin—76.80%
Operating margin—-9867.92%
Net margin—-9618.03%
52-week high$4.94$18.75
52-week low$1.06$2.00
Distance from 52-week high-74.29%-87.85%
Analyst consensus—buy
Avg. price target upside—+1546.25%
Average volume35.45K156.51K
Shares outstanding3.65M1.79M
Employees24
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Pulmatrix

PULM stock →

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

About Scienture

SCNX stock →

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

PULM vs SCNX FAQ

Which is bigger, Pulmatrix or Scienture?

Pulmatrix (PULM) is larger, with a market capitalization of $4.64M compared with $4.07M for Scienture (SCNX).

Are Pulmatrix and Scienture in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons